Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice  Mohammad A.

Slides:



Advertisements
Similar presentations
Volume 18, Issue 5, Pages (May 2010)
Advertisements

Molecular Therapy - Methods & Clinical Development
Development of a Rab9 Transgenic Mouse and Its Ability to Increase the Lifespan of a Murine Model of Niemann-Pick Type C Disease  Tatiana Kaptzan, Sally.
Cherie M Southwood, James Garbern, Wei Jiang, Alexander Gow  Neuron 
Athena Kalyvas, Samuel David  Neuron 
Volume 22, Issue 4, Pages (April 2014)
D.W Huang, L McKerracher, P.E Braun, S David  Neuron 
Volume 16, Issue 8, Pages (August 2008)
Taking Advantage of the Systemic Immune System to Cure Brain Diseases
VEGF Gene Delivery to Muscle
Molecular Therapy - Nucleic Acids
Volume 21, Issue 2, Pages (February 2013)
Volume 22, Issue 8, Pages (August 2014)
Volume 24, Issue 2, Pages (February 2016)
Volume 32, Issue 3, Pages (March 2010)
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 4, Pages (April 2008)
Volume 18, Issue 12, Pages (December 2010)
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 6, Pages (June 2008)
Volume 36, Issue 3, Pages (March 2012)
Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice  Zhi-Ming.
Volume 23, Issue 7, Pages (July 2015)
A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
Volume 24, Issue 5, Pages (May 2016)
Volume 23, Issue 5, Pages (May 2015)
Volume 24, Issue 8, Pages (August 2016)
Volume 20, Issue 5, Pages (May 2012)
Volume 16, Issue 8, Pages (August 2008)
Molecular Therapy - Methods & Clinical Development
Volume 19, Issue 1, Pages (July 1997)
Volume 18, Issue 9, Pages (September 2010)
Volume 25, Issue 12, Pages (December 2017)
Volume 25, Issue 3, Pages (March 2017)
Molecular Therapy - Methods & Clinical Development
Electron microscopy of the lumbar section of the spinal cord in EAE mice after vehicle or etifoxine treatment.A.Low magnification electron micrograph showed.
Volume 9, Issue 6, Pages (June 2004)
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Molecular Therapy - Methods & Clinical Development
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain  Cassia N. Cearley, John.
Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of niemann–pick.
Volume 71, Issue 7, Pages (April 2007)
Volume 17, Issue 5, Pages (May 2009)
Volume 12, Issue 4, Pages (October 2005)
Computer-assisted Hydrodynamic Gene Delivery
Volume 21, Issue 8, Pages (August 2013)
Volume 23, Issue 4, Pages (April 2015)
Volume 19, Issue 6, Pages (June 2011)
Volume 18, Issue 9, Pages (September 2010)
Volume 26, Issue 2, Pages (February 2018)
Volume 16, Issue 2, Pages (July 2016)
Volume 13, Issue 3, Pages (March 2006)
Volume 3, Issue 3, Pages (March 2001)
Probable Adult Polyglucosan Body Disease
Volume 20, Issue 9, Pages (September 2012)
Volume 18, Issue 6, Pages (June 2010)
Volume 8, Issue 2, Pages (August 2003)
Volume 23, Issue 3, Pages (March 2015)
Neuroprotection by Gene Therapy Targeting Mutant SOD1 in Individual Pools of Motor Neurons Does not Translate Into Therapeutic Benefit in fALS Mice  Chris.
Volume 25, Issue 3, Pages (March 2017)
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia  Dwight D Koeberl, B Sun, A Bird, YT Chen,
Volume 18, Issue 5, Pages (May 2010)
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
Volume 16, Issue 4, Pages (April 2008)
Volume 22, Issue 7, Pages (July 2014)
Molecular Therapy - Nucleic Acids
Volume 24, Issue 6, Pages (June 2016)
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Volume 23, Issue 4, Pages (April 2015)
Presentation transcript:

Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice  Mohammad A Rafi, Han Zhi Rao, Paola Luzi, David A Wenger  Molecular Therapy  Volume 23, Issue 11, Pages 1681-1690 (November 2015) DOI: 10.1038/mt.2015.145 Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Effects of bone marrow transplantation (BMT) and BMT + AAVrh10 treatments on lifespan, weight and gait. (a) Survival of the mice treated with BMT and AAVrh10 alone or in combination is compared to untreated affected and wild-type mice. Vertical blue and green upticks represent mice still living, red upticks refer to mice sacrificed for analysis. The asterisk indicates the mouse that died from gastrointestinal complication. (b) Weights of the mice treated with BMT only (n = 10) and BMT + AAVrh10 (n = 16) are compared to untreated affected (n = 9) and wild-type mice (n = 4). (c) Gait analysis. The footprints of mice were recorded as described in the Materials and Methods section. Footprints are from an 80-day-old wild-type mouse, a 42-day-old untreated affected mouse, a 150-day-old, and a 300-day-old combined treated mouse. Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Histochemical detection of galactocerebrosidase (GALC) activity using modified X-gal staining. All tissues are from a 150-day-old twi mouse treated with both BMT and AAVrh10. The blue color represents GALC activity. (a) Cortical region of the brain (original magnification ×100); (b) cross section of the cerebellum (original magnification ×40); (c) lumbar region of the spinal cord (original magnification ×100); and (d) cross section of the sciatic nerve (original magnification ×200). Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Pathological studies in central nervous system (CNS). Tissues from cerebral hemispheres, cerebellum, and spinal cord from different treated mice are compared to affected untreated and wild-type mice. All images are from paraffin sections stained with luxol-fast blue/periodic acid Schiff. Original magnifications for brain and spinal cords samples are ×600 and for cerebellum is ×400. Myelin is stained blue and infiltrating foamy macrophages are stained pink-red. BMT, bone marrow transplantation. Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Staining of activated microglia/macrophages in CNS of the 150-day-old BMT + AAVrh10-treated mouse compared to the 42-day-old untreated twitcher and 110-day-old wild-type mice. All images are from PFA-fixed frozen sections stained with CD68 antibody. Images (a) through (c) are from cerebral hemisphere white matter (original magnification ×100); images (d) through (f) are from cerebellum (original magnification ×200); images (g) through (i) are from spinal cord white matter (original magnification ×400). As shown in image c and f, brain and cerebellum of the mouse treated with combination of BMT and viral injection, sacrificed at PND150, do not have any CD68-positive cells. However, a section from the lumbar region of the spinal cord does show some staining for CD68 (i). BMT, bone marrow transplantation; CNS, central nervous system; PFA, paraformaldehyde. Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Astrocyte activation. All images are from PFA-fixed frozen sections stained with glial fibrillary acidic protein antibody that detects astrocytes. Image (a) is from a 110-day-old wild-type mouse, image (b) from 42-day-old untreated twi, image (c) from the 150-day-old BMT + AAVrh10-treated mouse, and image (d) from 224-day-old BMT + AAVrh10-treated mouse (all original magnifications are ×200). As shown in images c and d, the characteristic astrogliosis seen in the untreated twi mouse (image b) appears normal in the combined treated mice. BMT, bone marrow transplantation; PFA, paraformaldehyde. Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Pathological studies of peripheral nervous system. Cross sections from sciatic nerves of different treated mice are compared to the similar sections from affected untreated and wild-type mice. All images are from paraffin sections stained with luxol-fast blue/periodic acid Schiff. Original magnification for all tissues is ×1,000. The wild-type mouse shows normal myelination (a) while the 42-day-old untreated twi (b) has essentially no myelin and many macrophages. Also the 98-day-old twi mouse treated only with BMT (c) has lost essentially all myelin and is comparable to the untreated affected mouse. In contrast, sciatic nerves from mice of different ages treated with combined BMT/AAVrh10 (d–f) have completely normal looking myelin, and are comparable to the wild-type mouse. BMT, bone marrow transplantation. Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions

Figure 7 Ultra-structural studies of the peripheral nervous system. (a–d) Toluidine blue stained semi-thin sections of sciatic nerves from a wild-type mouse (a), untreated twi mouse (b), 150-day-old (c) and 334-day-old combined treated mice (d) are shown. Dark and fuzzy-looking axons in the 334-day-old treated mouse seem to be crush artifacts. Pictures from all sections are taken at ×600 magnification. (e–h) Electron micrographs from the same mice described above. The electron micrograph from a wild-type mouse shows a normal appearing density of large and small myelinated axons with intact axoplasm (e). While the image from untreated twi mouse rarely shows myelin structures and is filled with characteristic inclusions (f), the images from 150- and 334-day-old mice present normal looking myelinated axons with no infiltration of endoneurial macrophages (g,h). All original magnifications are ×4,000. Molecular Therapy 2015 23, 1681-1690DOI: (10.1038/mt.2015.145) Copyright © 2015 American Society of Gene & Cell Therapy Terms and Conditions